Mutations in FMS-like tyrosine kinase 3 (FLT3) occur in approximately 30% of AML and are frequently associated with normal karyotype, NPM1 mutations (40%), and DEK::NUP214-AML (70%) [88]. This evidence concerns the gene NUP214 and acute myeloid leukemia.